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Review Article
Strategies for Widening Liver Donor Pool
Ho Yu Chung, See Ching Chan, Chung Mau Lo and Sheung Tat Fan, Department of Surgery, 
The University of Hong Kong, Hong Kong SAR, China.
Liver transplantation is a life-saving treatment modality, but is hindered by the scarcity of deceased-donor
liver grafts. To acquire more liver grafts and thus save more lives, various techniques have been devised
and policies adopted, including living-donor, split-graft and sequential liver transplantation; extended
donor criteria; and donation after cardiac death. However, with these techniques and policies come a
range of entailed medical concerns and concomitant ethical dilemmas, mainly bearing on the welfare of
donors and potential donors. In this article, we provide an overview of how the transplant community
works towards the end of extending the liver donor pool, with the aim of ensuring that more liver trans-
plant candidates receive their transplant as early as possible. The current strategies in Hong Kong in this
regard are also reviewed. [Asian J Surg 2010;33(2):63–9]
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Introduction
Liver transplantation (LT) is an effective treatment for end-
stage liver disease of various etiologies, small unresectable
hepatocellular carcinoma, and inborn errors of metabolism
of liver origin. Unfortunately, this life-saving treatment is
limited by the availability of deceased-donor liver grafts.
Urged on by the shortage of grafts, the transplant com-
munity has devised techniques and adjusted policies to save
more lives. Here, we give a synopsis of how more liver trans-
plants are carried out by various means. The local practice
in Hong Kong in such an endeavour is also reported.
Living-donor liver transplantation (LDLT)
The idea of LDLT was first promulgated in 1969 by
Smith,1 only 2 years after the first success in deceased-
donor liver transplantation (DDLT) by Starzl et al2 in 1967.
The initial intention was to obtain transplant organs of
good quality when reliable organ preservation was not
available in the 1960s. However, despite a serious graft
shortage, it took two decades for LDLT to come into clinical
practice in 1989,3 underpinned by advances in surgical
techniques and therapeutics.
In DDLT, the shortage of paediatric liver grafts was
particularly severe. To overcome size disparity between
adult liver grafts and paediatric recipients, reduced-graft
LT was devised by Bismuth and Houssin in 1984.4 Through
extension of this concept, split-graft LT was developed by
Pichlmayr et al in 1988.5 Experience gained from in situ
donor hepatectomy in split-graft LT was subsequently
applied to LDLT. However, graft harvesting from a living
donor required much more technical ingenuity. The first
success was achieved by Strong et al in July 1989.3 Later, a
group led by Broelsch et al6 developed the first adult-to-
child LDLT programme. Small series of adult-to-child
LDLT were then reported in the United States7 and Europe.8
In Japan where deceased-donor graft donation was
nonexistent and liver surgery was well-developed, LDLT
flourished. For adult-to-adult LDLT, the left liver lobe
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was used initially by the Hashikura group.9 However,
adult-to-adult left-liver LDLT was often handicapped by
inadequate graft size. In 1993, Kyoto reported their improv-
isation on the operating table of using the right liver lobe
in a case of LDLT for a 9-year-old recipient.10 The intention
was to avoid precarious arterial anatomy of the left lobe.
The first case of adult-to-adult right-liver LDLT was per-
formed at Queen Mary Hospital, Hong Kong, on 9 May
1996. The first series was reported shortly afterwards.11
A priori, the right liver graft design includes the middle
hepatic vein. This design ensures excellent venous out-
flow capacity and thus addresses the problem of small-
for-size syndrome.12 Through continued development
and innovation, graft and recipient survival of adult-to-
adult LDLT now compare favourably with those of DDLT.
Recipients without hepatocellular carcinoma even have
an excellent 5-year survival rate of 93.4%.13 From 1991 to
2008, a total of 414 cases of LDLT were carried out at
Queen Mary Hospital (Figure 1).
Donor safety and well-being
As the application of LDLT extended from children to
adults, and from using the left lobe to using the right lobe,
the dilemma between recipient success and donor risk came
under the spotlight. The recipient needs a liver graft with at
least 35% of his/her estimated liver volume to meet his/her
metabolic requirements.14 However, the donor also needs to
have a remnant liver >30% of his/her original liver volume.15
The reported overall complication rate for LDLT donors
is around 20% but was as high as 67% in one review.16 One
donor death is too many for the transplant community,
and there have been at least 19 known donor deaths.17 The
changes in donors’ quality of life in comparison with their
pre-donation state are less tangible.18 The long-term biolog-
ical consequences of donor hepatectomy are yet to be com-
pletely established.19 Quantification of such is mandatory
in defining the field strength of LDLT. Efforts to improve
care of donors, while not depriving them of the chance of
saving or improving the life of their beloved recipients, are
worthy of investigation the transplant community.
Liver donation from altruistic living donors (2 cases,
2008) demands even more caution in potential-donor
assessment and preparation. The first paired donor-
interchange LDLT in Hong Kong was performed at
Queen Mary Hospital on 13 January 2009, in which two
simultaneous transplants were achieved by interchange
of donors to match the ABO blood group of the two
respective recipients; one with acute liver failure and the
other with Child–Pugh class C cirrhosis. The two donor
and recipient operations were performed simultaneously.
Split-graft liver transplantation
The initial idea of splitting a deceased-donor liver aimed
at surgical reduction of the graft for transplantation to a
paediatric or small-sized patient. However, in such a case, the
remaining major portion of the liver graft was wasted. This
reduction technique was later modified to create a left lat-
eral segment (LLS) graft for a paediatric recipient and a
right trisection (RTS) graft for an adult recipient at the
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Figure 1. Liver transplantation at Queen Mary Hospital (1991–2008).
same time. Pichlmayr et al5 and Bismuth et al20 were the
first groups to report their experience in creating two
grafts from one deceased-donor liver. Since then, many
other studies have supported the use of this method to
expand the donor pool.
Criteria
The criteria for being a split-graft donor are more restricted.
A deceased donor must be younger than 55 years old and
haemodynamically stable. Other parameters for consider-
ation of graft splitting include body weight, past medical
history, results of liver function tests, and electrolyte bal-
ance.21 In general, 15–20% of donors are eligible for split-
graft LT.22 The requirements of organ quality are more
demanding if full right and left split grafts are wanted.
Liver transection
The splitting procedure can be broadly divided into in situ
and ex situ splitting of the liver. The former has the advan-
tage of shorter cold ischaemic time but a longer duration
of the donor procedure. By convention, the ultimate out-
come is production of an LLS graft that includes Couinaud
segments 2 and 3 for a paediatric recipient, and an RTS
graft that includes Couinaud segments 1 and 4–8 for an
adult recipient. The line of splitting is to the right of the
falciform ligament. With increasing concern to expand
the donor pool for the adult population, some studies
have tried to produce two grafts from one liver for two
adult recipients, with a right graft including Couinaud
segments 5–8 and a left graft with Couinaud segments
1–4. In such cases, the line of splitting is Cantlie’s line.23
Yersiz et al24 published their experience of 100 cases of
in situ split-graft LT in 2003. In that series, 190 allografts
were obtained from 100 livers from September 1991 to
February 2003. The liver was divided in the conventional
manner into LLS and RTS grafts. A total of 165 grafts (LLS:
94, RTS: 71) were transplanted into 105 children and 60
adults. For split-graft LT using LLS graft for paediatric
patients, the 3-year graft survival rate was 64%, which was
slightly inferior to the reported 73% in whole-graft LT and
71% in LDLT using LLS grafts (p= 0.12). The 3-year recip-
ient survival rate for split-graft LT using LLS graft was
75%, whereas the whole-graft LT group had 81% survival and
the LDLT group using LLS graft had 84% (p = 0.01). As to
split-graft LT using RTS graft for adult recipients, the
overall 1-year graft survival rate was 69%, whereas the 1-year
recipient survival rate was 78%. The results were slightly
inferior to the commonly quoted 80% graft and 90% recip-
ient survival rates at 1 year for DDLT.
Split-graft LT using LLS grafts and split-graft LT using
RTS grafts have similar complications. With respect to
biliary and vascular complications, LLS-graft split-graft LT,
LLS-graft LDLT and paediatric whole-graft LT show simi-
lar outcomes. Yet, LLS grafts of split-graft LT have a higher
incidence of primary non-function. For RTS grafts of split-
graft LT, the outcomes are more controversial. Encouraging
results have come from a recent study by Corno et al pub-
lished in 2006.25 The 5-year graft and patient survival rates
for split-graft LT using RTS grafts were both 94%. In that
series, RTS grafts were also transplanted to 10 paediatric
recipients by split-graft LT. An excellent outcome with
100% 5-year graft and patient survival rates was achieved.
Adult–adult recipients
With initially successful experience in split-graft LT for
adult–child recipients, split-graft LT has been extended to
adult–adult recipients in order to alleviate the grave graft
shortage for adult recipients, which accounts for > 95% of
waiting-list deaths.
In a study on split-graft LT for two adult recipients by
Azoulay et al,26 there was no difference in graft survival
between whole and right split grafts. The survival of left
split grafts, however, was significantly lower at 2 years
(43%) compared with whole grafts (85%; p = 0.003). For
patient survival, there was no significant difference between
patients who received whole grafts, right split grafts, or
left split grafts at 2 years (85%, 74% and 64%, respectively),
with the result of re-transplantation for failing left split
grafts taken into account.
At Queen Mary Hospital, a total of 260 cases of DDLT
have been carried out in the past 17 years, among which,
229 were whole-graft LT, 21 were split-graft LT, and 10
were reduced-graft LT (Figure 2).
Extended donor criteria (EDCs)
Traditional donor selection is based on the strict criteria
laid down by the transplant registry. However, to meet the
ever-increasing demand for liver donors, some centres have
advocated relaxation of customary restrictions on dona-
tion for donor-pool expansion. Contrary to general belief,
there are only a few absolute contraindications to liver
donation. These include transmissible diseases and high-
grade extracranial primary malignancies or metastases.
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On the other hand, the suitability of a liver to be a graft is
only limited by its gross functional or structural deficiency.
Donor characteristics
At present, there is still no standard definition for EDCs. In
general, EDCs signify donor characteristics that are asso-
ciated with higher risks of graft failure or disease trans-
mission, including age >65 years, macrovesicular steatosis
> 40%, serum sodium > 155 mmol/L, positive serological
data, carcinoma outside the liver, donation after cardiac
death, and split-graft LT.
Clinical trials
A retrospective analysis of 116 standard-criteria recipients
and 99 EDC recipients was conducted at the Center for
Liver Disease and Transplantation in New York.27 The 3-year
patient survival rate was 80% for standard-criteria recipi-
ents and 78% for EDC recipients (not significant). The EDC
recipients demonstrated a higher incidence of graft failure
that resulted in re-transplantation or death, but the dif-
ference did not reach statistical significance. The 3-year
graft survival rates for both groups were exactly the same
as the respective 3-year patient survival rates.
Donor age >40 years, donation after cardiac death and
partial graft are factors that adversely affect graft survival.
Grafts harvested under these criteria can well be utilised in
recipients who have moderately severe illness and without
hepatitis C.28
Sequential LT
In sequential LT, the first transplant is from a deceased or
living donor to a recipient who has familial amyloidosis.
This recipient is also a donor, called a domino donor,
because his/her own liver is subsequently transplanted to
another recipient, called the domino recipient, who has
end-stage liver disease. The feasibility of such practice is
based on the pathogenesis of familial amyloidosis. It is a
disease caused by the mutated transthyretin gene, induc-
ing adverse effects to blood vessels, nerve tissues and
organs including the liver. However, the related symp-
toms usually take 20–30 years to develop. The technique
of sequential LT was first developed by Furtado et al29 in
1995. In Queen Mary Hospital, until 2008, four cases of
sequential LT had been carried out (Figure 2).
Technical challenges
Most sequential LTs have living donors as first donors
because deceased donors are very scarce. A major concern
in domino LDLT is to ensure the safety of the living and the
domino donors. The graft from a living donor is usually
smaller than a deceased-donor graft. Furthermore, the vas-
cular cuffs of a living-donor graft are shorter for anasto-
mosis. As a result, it is necessary to leave the hepatic vessels
as long as possible when removing the liver from the
domino donor, which renders very short the vessels that
are attached to the domino graft, thus causing technical
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Figure 2. Liver transplantation by different techniques at Queen Mary Hospital (1991–2008).
difficulties in transplantation. Careful decision making
during division of vessels, in addition to experience gained
from LDLT can help to tackle this problem.
Results
A review of sequential LT was published by Nunes et al in
2004.30 The series consisted of 41 cases among 207 trans-
plants from April 1999 to December 2002. It confirmed
the importance of sequential LT in increasing the num-
ber of available grafts for transplantation. The percentage of
transplants was increased significantly from 12.5% in 1999
to 24.5% in 2002. Nevertheless, amyloidosis could be man-
ifest in recipients as early as 2 years after transplantation, as
reported by Goto et al.31 A study by Delahaye et al32 also has
indicated that domino donors might not have their symp-
toms relieved, and those with prior cardiac sympathetic den-
ervation might have further deterioration in the first 2 years.
Dual-graft LT
Graft size is one of the major determining factors for a
successful transplantation outcome, therefore it is essential
that the recipient obtains a graft of appropriate size. In
LDLT, the use of the right liver usually allows this criterion
to be met, but the remaining left liver might be insufficient
for the donor. If this happens, the donor should not be
allowed to donate his/her liver. To tackle the problem of
inadequate graft size, one innovative approach is to trans-
plant the recipient with two left-lobe grafts from two
donors. With this approach, dual-graft LT, the donors and
the recipient can all have an appropriately sized liver after
transplantation. In selected cases, the left lateral lobe can
be used and donor morbidity is further reduced; successful
cases have been reported.33
Donation after cardiac death
A deceased donor is either heart-beating or non-heart-
beating (cardiac-dead). Heart-beating death is determined
by irreversible cessation of all brain functions, whereas car-
diac death is characterized by simultaneous and irreversible
unresponsiveness, apnoea, and absence of circulation.
Organs harvested from cardiac-dead donors are subjected
to longer warm ischaemia over the period from circulatory
dysfunction and arrest to perfusion and cooling. A liver
graft can only tolerate warm ischaemia of up to 30 min-
utes,34 therefore, the organ procurement procedure has to
be performed swiftly to avoid extending the already longer
warm ischaemic time. The Pittsburgh super-rapid tech-
nique features cannulation of the aorta and flushing with
5 L of cold University of Wisconsin solution. Premortem
cannulation of femoral vessels allows infusion of preserva-
tion solution right after declaration of death.35
Maastricht categories
In the early 1990s, investigators from the Netherlands
described four categories of cardiac death, which are known
as the Maastricht categories: (I) death on arrival; (II) unsuc-
cessful resuscitation; (III) awaiting cardiac arrest; and (IV)
cardiac arrest while brain dead.36 The fourth category
includes unsuccessful resuscitation after unexpected car-
diac arrest in intensive care. The first, second and fourth
categories are categorized as the uncontrolled group in
which cardiac death is unexpected. Warm ischaemic time
for organs harvested from this group is variable but often
long. Conversely, the third group is termed the controlled
group because the organ retrieval team can be mobilized
prior to withdrawal of life support to the donor, and warm
ischaemia is not prolonged. Lately, most cardiac deaths in
reported series of post-cardiac-death organ donation have
belonged to the controlled group.
Results
The Pittsburgh programme was among the first to report
the results of cardiac-death LT. In 1995, a series of six 
controlled-cardiac-death-liver recipients had a graft sur-
vival rate of 50%.35 In a study in 2000, the Madison pro-
gramme compared 19 cases of controlled-cardiac-death LT
with 364 cases of heart-beating-donor LT.37 The 3-year
patient survival rate of the cardiac-death group was simi-
lar to that of the heart-beating-donor group (72.6% vs.
84.8%, p = 0.36). The 3-year graft survival rate, however,
was lower in the cardiac-death group (53.8% vs. 80.9%,
p = 0.007). It is worth noting that half of the graft losses
were due to patient death with normal liver graft function.
Subsequent reports from 2000 to 2004 showed that the
graft and patient survival rates after cardiac-death LT ranged
from 53.8% to 100% and 72.6% to 100%, respectively.38
A recent series from Philadelphia39 has compared 
16 cases of controlled-cardiac-death LT with 221 of heart-
beating-donor LT. The patient and graft survival rates after
3 years were similar between the two groups. The graft sur-
vival rates were 71.8% and 73.9% (p=0.68), respectively, and
the patient survival rates were 79.0% and 77.0% (p=0.8).
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Common complications
Three types of graft-related complications after cardiac-
death LT have been reported: complications of vascular
origin, primary nonfunction, and biliary strictures.
Vascular complications are mainly hepatic artery throm-
bosis. According to various studies, the occurrence of
hepatic artery thrombosis after cardiac-death LT can be
as high as 5.3%.37 Cardiac-death liver grafts have a higher
primary non-function rate. Studies have reported a
6.7–10.5% primary nonfunction rate in a cardiac-death
group, whereas it was 1.3–3.6% in the corresponding
heart-beating-donor group.37,39,40 This outcome was likely
to have been a result of prolonged warm ischaemia in the
cardiac-death group. In a study by Abt et al,39 the rate of
major biliary complications in the cardiac-death group
was 33.3% (5/25 patients) and that in the heart-beating-
donor group was 9.5% (21/221 patients; p < 0.01). The
heart-beating-donor group had a higher rate of anasto-
motic stricture (46.2% vs. 16.7%), whereas the cardiac-
death group had a higher rate of ischaemic-type stricture
(66.6% vs. 19.2%). Intrahepatic ischaemic stricture is related
to warm ischaemic time, therefore, it is not surprising
that patients in the cardiac-death group suffered more
ischaemic-type biliary stricture.
Ethical issues
Controversy remains in defining controlled cardiac death
as to whether loss of cardiac electrical activity or absence
of heart sounds, pulse and blood pressure is sufficient.
The waiting time after cardiac arrest is also variably deter-
mined. The Maastricht workshop has maintained that 10
minutes are required,36 whereas the group from King’s
College Hospital (London, UK) waits for only 5 minutes,41
and the Pittsburgh group for 2 minutes.42 The 5-minute
and 10-minute periods have the benefit of rendering cardiac
death de facto brain-dead.
The results of cardiac-death LT are constantly improv-
ing. Further refinements in donor selection, graft procure-
ment and ethical guidelines should strengthen cardiac-death
LT as a valuable clinical endeavour.
Artificial organ support and others
The molecular adsorbents recirculating system works as a
bridge to LT by keeping a potential recipient’s condition
suitable for transplantation during the waiting time that
might be extended for various reasons.43 Although this
system can extend the waiting time for several days, it can-
not replace transplantation.
In paediatric patients, the commonest cause for LT is
biliary atresia, for which the Kasai operation might not be
curative in the long term, but an initial successful opera-
tion can delay the need for LT for a few years by making
the patient’s condition less critical.
To ease the heavy demand for liver grafts, reducing the
need for LT should be the primary strategy. To reduce the need
for LT, we should strive to minimize the chances of cirrho-
sis, hepatocellular carcinoma, and liver failure. This can be
achieved by effective screening of patients with hepatitis
B or C and give them proper therapies.
Conclusion
In the near future, liver donation will be mainly from
brain-dead donors in the west and living donors in the
east. Through education and motivation, the supply of
deceased-donor livers might increase and therefore pro-
mote DDLT. As to LDLT, the use of marginal, split, sequen-
tial and cardiac-death grafts boosts its use markedly. The
cost-effectiveness of LDLT will improve with better survival
of recipients and lower risks for donors. These can be
attained through continuing audit and research on LDLT.
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